Position in LLY
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$59,220,661
+$16,615,995 QoQ
Shares Held
49,374
+6.6% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
1.37%
of 13F equity value
Holder Rank
#506
of 4,605 holders
Holding Since
Dec 2024
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Banque Transatlantique SA holds $103,275,926 across 11 Drug Manufacturers - General names. LLY ranks #1 (57.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
49,374 | $59,220,661 | |
| 2 | JNJ |
Johnson & Johnson
|
90,610 | $23,012,221 | |
| 3 | AZN |
Astrazeneca PLC
|
63,714 | $12,081,448 | |
| 4 | MRK |
Merck & Co., Inc.
|
35,317 | $4,538,234 | |
| 5 | ABBV |
AbbVie Inc.
|
5,858 | $1,474,107 | |
| 6 | AMGN |
Amgen Inc
|
3,698 | $1,339,119 | |
| 7 | PFE |
Pfizer Inc
|
27,165 | $654,133 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
4,060 | $512,940 |
All Filings in LLY
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $59,220,661 | 49,374 | Shares | Defined | 2026-07-30 | |
| 2026-03-31 | $42,604,666 | 46,321 | Shares | Defined | 2026-05-13 | |
| 2025-09-30 | $103,454,407 | 135,589 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $115,148,273 | 147,715 | Shares | Defined | 2025-08-14 | |
| 2024-12-31 | $106,713,560 | 138,230 | Shares | Defined | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||